BREAKING
Home » Posts Tagged "Emergent BioSolutions"
Bacillus anthracis bacteria using Gram-stain technique

Anthrax vaccine, BioThrax, receives Health Canada nod

By

Emergent BioSolutions Inc. today announced that Health Canada has approved the company’s New Drug Submission (NDS) for its anthrax vaccine, BioThrax® (Anthrax Vaccine Adsorbed). BioThrax is indicated...

Nipah virus: $25 million agreement to advance the development and manufacture of a vaccine

By

CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent BioSolutions Inc. under which Profectus and Emergent will receive...

Emergent BioSolutions to expand market of anthrax vaccine, BioThrax, in Europe

By

Emergent BioSolutions Inc. announced this week the successful completion of the Mutual Recognition Procedure (MRP) for market authorization of BioThrax® (Anthrax Vaccine Adsorbed) in five Concerned...

Bioterrorism threats: Anthrax vaccine contract, botulism antitoxin approval in Canada

By

Last week, Gaithersburg, MD based biopharmaceutical company, Emergent BioSolutions Inc. announced the signing of a nearly $1 billion contract with the Centers for Disease Control and Prevention (CDC)...